Literature DB >> 33245675

CT-guided transthoracic needle biopsy of pulmonary lesions: comparison between the cutting needle and aspiration needle.

Zhen-Guo Huang1, Hong-Liang Sun1, Cun-Li Wang2, Bao-Xiang Gao1, He Chen1, Min-Xing Yang1, Xiao-Liang Chen1.   

Abstract

OBJECTIVES: To compare CT-guided transthoracic cutting needle biopsy (TCNB) with transthoracic aspiration needle biopsy (TANB) for pulmonary lesions with respect to the diagnostic accuracy and complication rate.
METHODS: Of the 859 cases that underwent consecutive CT-guided biopsy of pulmonary lesions, 713 cases confirmed by surgical pathology or clinical follow-up were enrolled. Of these, the first consecutive 275 cases underwent TANB, and the remaining 438 received TCNB. The final diagnosis determined the accuracy of biopsy. Based on the post-biopsy CT and clinical medical records, the presence or absence of biopsy-related complications was determined. The χ2 test was used to compare the differences between TCNB and TANB in terms of diagnostic accuracy and complication rate.
RESULTS: Among the 713 biopsy lesions, the final diagnosis was malignant in 411 cases and benign in 302 cases. As compared to TANB, the diagnostic accuracy of TCNB (98.9% vs 93.8%, χ2 = 14.35, p < 0.01), sensitivity to malignant lesions (97.8% vs 90.6%, χ2 = 10.58, p < 0.01), negative predictive value (97.6% vs 84.8%, χ2 = 19.03, p < 0.01), and specific diagnostic rate for benign lesions (73.4% vs 57.9%, χ2 = 7.29, p < 0.01) were improved. On the other hand, a statistical difference was detected between TCNB and TANB with respect to the incidence of pneumothorax (20.6% vs 13.1%, χ2 = 6.46, p = 0.01), hemorrhage (32.2% vs 13.1%, χ2 = 33.03, p < 0.01), and hemoptysis (8.2% vs 3.3%, χ2 = 6.87, p < 0.01). One patient died just several minutes after TCNB due to severe hemorrhage with hemoptysis.
CONCLUSIONS: Compared to TANB, CT-guided TCNB improves the diagnostic accuracy of pulmonary lesions, but complication rate increases significantly. ADVANCES IN KNOWLEDGE: In general, TCNB should be recommended, especially for highly suspicious benign lesions. For patients with small lesions adjacent to vessels or vessels within the lesion, TANB should be considered.

Entities:  

Mesh:

Year:  2020        PMID: 33245675      PMCID: PMC7934311          DOI: 10.1259/bjr.20190930

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  27 in total

1.  Diagnostic accuracy of CT-guided automated needle biopsy of lung nodules.

Authors:  H Tsukada; T Satou; A Iwashima; T Souma
Journal:  AJR Am J Roentgenol       Date:  2000-07       Impact factor: 3.959

2.  CT-guided lung biopsy: factors influencing diagnostic yield and complication rate.

Authors:  J M Anderson; J Murchison; D Patel
Journal:  Clin Radiol       Date:  2003-10       Impact factor: 2.350

Review 3.  Trans-thoracic biopsy of lung lesions: FNAB or CNB? Our experience and review of the literature.

Authors:  Emanuela Capalbo; Michela Peli; Maria Lovisatti; Maria Cosentino; Paola Mariani; Eisabetta Berti; Maurizio Cariati
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

4.  Diagnostic Accuracy and Safety of CT-Guided Percutaneous Transthoracic Needle Biopsies: 14-Gauge versus 22-Gauge Needles.

Authors:  Sebahat Ocak; Fabrice Duplaquet; Jacques Jamart; Lionel Pirard; Birgit Weynand; Monique Delos; Philippe Eucher; Benoît Rondelet; Michael Dupont; Luc Delaunois; Yves Sibille; Caroline Dahlqvist
Journal:  J Vasc Interv Radiol       Date:  2016-03-24       Impact factor: 3.464

5.  Transthoracic Computed Tomography-Guided Lung Nodule Biopsy: Comparison of Core Needle and Fine Needle Aspiration Techniques.

Authors:  Bippan S Sangha; Cameron J Hague; Jennifer Jessup; Robert O'Connor; John R Mayo
Journal:  Can Assoc Radiol J       Date:  2016-03-19       Impact factor: 2.248

6.  Percutaneous core needle biopsy vs. fine needle aspiration in diagnosing benign lung lesions.

Authors:  J Greif; S Marmor; Y Schwarz; A N Staroselsky
Journal:  Acta Cytol       Date:  1999 Sep-Oct       Impact factor: 2.319

7.  Percutaneous CT-guided core needle biopsy versus fine needle aspiration in diagnosing pneumonia and mimics of pneumonia.

Authors:  Loukas Thanos; Panagiota Galani; Sophia Mylona; Maria Pomoni; Nikolaos Mpatakis
Journal:  Cardiovasc Intervent Radiol       Date:  2004-06-03       Impact factor: 2.740

8.  Factors affecting diagnostic accuracy of CT-guided coaxial cutting needle lung biopsy: retrospective analysis of 631 procedures.

Authors:  Kee-Min Yeow; Pei-Kwei Tsay; Yun-Chung Cheung; Kar-Wai Lui; Kuang-Tse Pan; Andy Shau-Bin Chou
Journal:  J Vasc Interv Radiol       Date:  2003-05       Impact factor: 3.464

9.  Percutaneous CT-guided fine-needle aspiration of pulmonary lesions: Results and complications in 409 patients.

Authors:  F Laspas; A Roussakis; R Efthimiadou; D Papaioannou; S Papadopoulos; J Andreou
Journal:  J Med Imaging Radiat Oncol       Date:  2008-10       Impact factor: 1.735

Review 10.  Transthoracic needle biopsy of the lung.

Authors:  David M DiBardino; Lonny B Yarmus; Roy W Semaan
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

View more
  3 in total

1.  CT-Guided Percutaneous Core Needle Biopsy in Typing and Subtyping Lung Cancer: A Comparison to Surgery.

Authors:  Hanfei Zhang; Sufang Tian; Shan Wang; Songmei Liu; Meiyan Liao
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

2.  Improving CT-guided transthoracic biopsy diagnostic yield of lung masses using intraprocedural CT and prior PET/CT fusion imaging.

Authors:  Yue Lin; Yanyan Xu; Jie Lin; Liping Fu; Hongliang Sun; Zhenguo Huang; Bee Yen Ooi; Sheng Xie
Journal:  BMC Pulm Med       Date:  2022-08-13       Impact factor: 3.320

3.  Efficacy and Safety Analysis of Multislice Spiral CT-Guided Transthoracic Lung Biopsy in the Diagnosis of Pulmonary Nodules of Different Sizes.

Authors:  Huitong Liu; Xiao Yao; Bingqiang Xu; Wei Zhang; Yu Lei; Xiaolong Chen
Journal:  Comput Math Methods Med       Date:  2022-08-25       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.